Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 11(9): e0162367, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27598339

RESUMO

To study the neuronal deficits in neuronopathic Gaucher Disease (nGD), the chronological behavioral profiles and the age of onset of brain abnormalities were characterized in a chronic nGD mouse model (9V/null). Progressive accumulation of glucosylceramide (GC) and glucosylsphingosine (GS) in the brain of 9V/null mice were observed at as early as 6 and 3 months of age for GC and GS, respectively. Abnormal accumulation of α-synuclein was present in the 9V/null brain as detected by immunofluorescence and Western blot analysis. In a repeated open-field test, the 9V/null mice (9 months and older) displayed significantly less environmental habituation and spent more time exploring the open-field than age-matched WT group, indicating the onset of short-term spatial memory deficits. In the marble burying test, the 9V/null group had a shorter latency to initiate burying activity at 3 months of age, whereas the latency increased significantly at ≥12 months of age; 9V/null females buried significantly more marbles to completion than the WT group, suggesting an abnormal response to the instinctive behavior and an abnormal activity in non-associative anxiety-like behavior. In the conditional fear test, only the 9V/null males exhibited a significant decrease in response to contextual fear, but both genders showed less response to auditory-cued fear compared to age- and gender-matched WT at 12 months of age. These results indicate hippocampus-related emotional memory defects. Abnormal gait emerged in 9V/null mice with wider front-paw and hind-paw widths, as well as longer stride in a gender-dependent manner with different ages of onset. Significantly higher liver- and spleen-to-body weight ratios were detected in 9V/null mice with different ages of onsets. These data provide temporal evaluation of neurobehavioral dysfunctions and brain pathology in 9V/null mice that can be used for experimental designs to evaluate novel therapies for nGD.


Assuntos
Envelhecimento/patologia , Doença de Gaucher/fisiopatologia , Glucosilceramidase/genética , Hipocampo/fisiopatologia , Transtornos da Memória/fisiopatologia , Estimulação Acústica , Envelhecimento/genética , Animais , Comportamento Animal , Condicionamento Psicológico/fisiologia , Modelos Animais de Doenças , Progressão da Doença , Comportamento Exploratório/fisiologia , Medo/fisiologia , Feminino , Marcha/fisiologia , Doença de Gaucher/metabolismo , Doença de Gaucher/patologia , Glucosilceramidase/deficiência , Glucosilceramidas/biossíntese , Hipocampo/metabolismo , Hipocampo/patologia , Masculino , Transtornos da Memória/metabolismo , Transtornos da Memória/patologia , Camundongos , Psicosina/análogos & derivados , Psicosina/biossíntese , Fatores Sexuais , Memória Espacial/fisiologia , alfa-Sinucleína/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...